Excelsior R&D Tax Credit

The modern fiscal policy of New York State is characterized by an intricate balance between aggressive economic development and strict accountability. Within this framework, the Excelsior Jobs Program (EJP) functions as the state’s primary vehicle for attracting and retaining high-value industries. Central to this program is the Excelsior Research and Development (R&D) Tax Credit. Unlike traditional tax deductions that merely reduce taxable income, the Excelsior R&D credit is a direct reduction of tax liability, and crucially, it is fully refundable. For innovative firms—particularly those in the pre-revenue stages of biotechnology or hardware development—this refundability transforms a tax incentive into a critical source of non-dilutive capital. To understand the Excelsior R&D credit, one must view it not as a standalone benefit, but as a component of a broader “pay-for-performance” architecture that replaced the older, more permissive Empire Zones Program. This report provides a comprehensive analysis of the credit’s legal foundations, its interaction with federal law, and the specific guidance provided by New York’s revenue and economic development offices.

Statutory Foundations and the Evolution of New York State R&D Incentives

The legal authority for the Excelsior Research and Development Tax Credit resides in New York Consolidated Laws, Economic Development Law – COM § 355. This statute identifies the R&D component as one of five potential credits available to participants in the Excelsior Jobs Program. The shift to the Excelsior model in 2010 marked a significant departure from previous incentive structures. Under the predecessor Empire Zones Program, businesses often received benefits “as-of-right” if they were located within certain geographic boundaries. The Citizens Budget Commission (CBC) has noted that the transition to the Excelsior program introduced four critical criteria: targeting specific strategic industries, offering short-term benefits to bridge companies to profitability, establishing pre-determined eligibility thresholds, and ensuring performance-based allocation.

The Discretionary Nature of the Program

A primary distinction of the Excelsior R&D credit compared to many other state-level R&D incentives is its discretionary nature. Admission to the program is not guaranteed by meeting technical definitions alone; it requires approval from the Commissioner of Empire State Development (ESD). This discretion allows the state to manage its fiscal exposure through an annual program cap, which has historically ranged from $50 million to $250 million for new commitments in a given year, contributing to a total program lifetime value originally set at $2.25 billion and subsequently expanded.

Strategic Industries and Economic Targeting

New York State limits participation in the Excelsior Jobs Program to industries deemed “Strategic.” This targeting ensures that the R&D credit is applied toward sectors with high growth potential and high multiplier effects for the regional economy. The following table outlines the minimum job creation requirements for these strategic industries under the Job Growth Track, which accounts for 75 percent of the program’s activity.

Strategic Industry	Minimum Net New Jobs Required	Regionally Significant Project Thresholds
Scientific R&D	5 Jobs	10 Jobs & $3,000,000 Investment
Software Development	5 Jobs	N/A
Manufacturing	5 Jobs	10 Jobs & $1,000,000 Investment
Agriculture	5 Jobs	10 Jobs & $250,000 Investment
Life Sciences	5 Jobs	20 Jobs & N/A
Financial Services	25 Jobs	100 Jobs & $3,000,000 Investment
Back Office	25 Jobs	100 Jobs & $3,000,000 Investment
Distribution	50 Jobs	100 Jobs & $15,000,000 Investment
Music Production	5 Jobs	N/A
Entertainment	100 Jobs	200 Jobs & N/A

Firms that cannot meet these specific job creation targets may still qualify under the Investment Track if they retain at least 25 to 50 employees (depending on the industry) and meet a rigorous benefit-cost ratio of at least $10 of investment and new wages for every $1 of tax credit awarded.

Technical Mechanics of the Excelsior R&D Credit Calculation

The calculation of the Excelsior R&D credit is unique among state credits because it is fundamentally a “derivative” of the federal research tax credit under Internal Revenue Code (IRC) Section 41. The state credit does not independently define research activities; instead, it adopts the federal definitions but limits the scope to expenditures within New York State.

The Two-Pronged Calculation Formula

Under COM § 355(3), the credit is calculated as 50 percent of the portion of the participant’s federal research and development tax credit that relates to expenditures in New York State. However, the state imposes an additional limit to prevent the credit from exceeding a certain percentage of total New York qualified research expenses (QREs).

The credit awarded is the lesser of:

1. 50% of the federal R&D credit relating to New York expenditures.
2. A percentage cap applied to total New York State research expenditures.

The percentage caps are currently set as follows:

• Traditional Strategic Projects: 6 percent of research expenditures.
• Semiconductor Supply Chain Projects: 7 percent of research expenditures.
• Green Projects / Green CHIPS: 8 percent of research expenditures.

Legislative Stability Provisions

An important nuanced detail in the law addresses the potential expiration of the federal credit. COM § 355(3) stipulates that if the federal R&D credit expires, the New York credit shall be calculated as if the federal research and development credit structure and definition in effect in 2009 were still in effect. This provision provides long-term certainty for New York firms, shielding them from the legislative volatility of the United States Congress.

Interaction with the Broader New York R&D Credit Ecosystem

A frequent point of professional inquiry involves how the Excelsior R&D credit interacts with other New York State incentives, specifically the Qualified Emerging Technology Company (QETC) R&D Credit and the Life Sciences Research and Development Tax Credit Program.

Excelsior R&D vs. QETC R&D Credit

The QETC R&D Credit, codified under Public Authorities Law § 3102-e, is designed for smaller, emerging tech companies with total annual product sales of $10 million or less. While the Excelsior R&D credit is performance-based and discretionary, the QETC credit is often viewed as a more “as-of-right” incentive for those meeting the statutory definitions of an emerging technology company.

Comparison Detail	Excelsior R&D Tax Credit	QETC R&D Tax Credit
Primary Value	50% of Federal Credit portion	18% of QREs over a base amount
Maximum Annual Limit	Allocated by ESD Certificate	$250,000 per year per taxpayer
Treatment of Excess Credit	Fully Refundable	Non-refundable; 15-year carryforward
Duration of Benefit	10 Consecutive Years	3 Consecutive Years
Sales Restriction	None (Strategic industry focus)	$10 million or less annual sales

For many high-growth firms, the Excelsior program is more attractive due to the refundability of the credit and the higher potential dollar value for large-scale research operations. However, the QETC credit remains a vital tool for very early-stage startups that may not yet meet the job creation thresholds required by the Excelsior Jobs Program.

Interaction with the Life Sciences R&D Tax Credit

Firms that do not participate in the Excelsior Jobs Program may be eligible for the Life Sciences Research and Development Tax Credit Program. This program offers a 15 percent credit for companies with 10 or more employees and a 20 percent credit for those with fewer than 10 employees. This credit is also fully refundable but is capped at $500,000 per year for a maximum of three years, creating a lifetime cap of $1.5 million per company. New York Tax Law generally prohibits “double-dipping,” meaning a taxpayer cannot claim both the Excelsior R&D credit and the Life Sciences R&D credit for the same expenditures.

Revenue Office Guidance: Application, Certification, and Claiming

Claiming the Excelsior R&D credit involves a dual-agency process. Empire State Development (ESD) handles the application and certification of eligibility, while the New York State Department of Taxation and Finance (DTF) manages the filing and refund process.

The Certification Lifecycle

A business cannot simply claim the Excelsior R&D credit on its annual tax return without prior authorization. The process begins with the Consolidated Funding Application (CFA) submitted to the regional ESD office.

1. Certificate of Eligibility: Issued upon acceptance into the program, this document outlines the preliminary schedule of benefits over a 10-year period.
2. Annual Performance Report: Within 30 days of the end of each taxable year, the firm must submit a report to ESD proving it met the required job and investment targets.
3. Certificate of Tax Credit: Once the performance report is verified, ESD issues a certificate for that specific tax year. This certificate specifies the exact dollar amount of the R&D credit component that the taxpayer is authorized to claim.

Filing Forms: CT-607 and IT-607

The DTF provides specific forms for claiming the credit. General business corporations file Form CT-607, while individuals, partners, and S-corporation shareholders file Form IT-607.

• Schedule C (Form CT-607): This section is dedicated to the Excelsior R&D tax credit component. Taxpayers must enter the amount directly from their annual ESD certificate.
• Coordination with Federal Form 6765: Because the credit is tied to the federal R&D credit, the DTF requires taxpayers to maintain records of their federal filing and the specific allocation of QREs to New York State.
• Refundability and Minimum Tax: For Article 9-A taxpayers, the credit is fully refundable but cannot reduce the tax due below the fixed dollar minimum tax. Any excess is then issued as a refund or credited to the following year’s tax.

Detailed Mathematical Example and Case Study

To illustrate the application of these rules, consider a hypothetical biotechnology firm, “Aurelius Therapeutics,” based in the Finger Lakes region.

Project Data for Tax Year 2024

Aurelius Therapeutics is an admitted participant in the Excelsior Jobs Program under the Job Growth Track for Scientific R&D. In 2024, they reported the following:

• Total Federal QREs: $4,000,000
• New York State QREs: $3,000,000 (75% of research activities conducted in Rochester, NY)
• Calculated Federal R&D Credit (Form 6765): $400,000

Step 1: Determine the New York Portion of the Federal Credit

The federal credit must be prorated to reflect only the New York portion of the research.

$$NYS\ Portion\ of\ Federal\ Credit = \$400,000 \times \left( \frac{\$3,000,000}{\$4,000,000} \right) = \$300,000$$

Step 2: Apply the 50% Rule

The Excelsior credit starts at 50% of this prorated federal amount.

$$Potential\ Excelsior\ Credit = \$300,000 \times 50\% = \$150,000$$

Step 3: Apply the Expenditure Cap (6%)

The law caps the credit at 6% of the actual NYS expenditures.

$$Expenditure\ Cap = \$3,000,000 \times 6\% = \$180,000$$

Result

Because the 50% rule result ($150,000) is lower than the expenditure cap ($180,000), Aurelius Therapeutics is eligible for an Excelsior R&D Tax Credit of $150,000. This amount will be listed on their 2024 Certificate of Tax Credit issued by ESD and subsequently claimed on Form CT-607.

Enhanced Incentives for Green Projects and Semiconductor Manufacturing

The New York State legislature has recently introduced enhancements to the Excelsior Jobs Program to address global shifts toward sustainability and domestic semiconductor reshoring. These “Green Project” and “Green CHIPS” enhancements significantly increase the value of the R&D credit.

Defining the “Green Project”

A green project is defined as one primarily aimed at reducing greenhouse gas emissions or supporting clean energy technologies. For companies in agriculture, manufacturing, software, or scientific R&D that qualify as green projects, the R&D credit cap is increased from 6 percent to 8 percent of NYS research expenditures.

The Green CHIPS and Semiconductor Supply Chain Initiatives

To compete for federal funding under the CHIPS and Science Act, New York established the Green CHIPS program. This is specifically for semiconductor manufacturing projects that meet massive thresholds: at least 500 net new jobs and $3 billion in investment.

• Green CHIPS R&D Credit: Eligible for the 8 percent expenditure cap.
• Semiconductor Supply Chain R&D Credit: For projects supporting the growth of the semiconductor sector (even if below the Green CHIPS thresholds), the R&D credit is enhanced to a 7 percent expenditure cap.

These enhancements are not merely numerical; they represent a strategic intent to lower the long-term R&D costs for companies building the next generation of power electronics and renewable energy infrastructure in the state.

Compliance, Documentation, and Audit Preparedness

Given the discretionary nature of the Excelsior program and the large dollar amounts involved in R&D credits, audit risk is a significant consideration. The DTF and ESD maintain strict accountability standards.

The Four-Part Test for Qualified Research

To qualify for the federal credit (and thus the Excelsior credit), activities must meet the Internal Revenue Code’s four-part test:

1. Technological in Nature: The research must rely on the principles of physical science, biological science, engineering, or computer science.
2. Permitted Purpose: The activity must involve the creation of a new or improved business component (product, process, or software) regarding its function, performance, reliability, or quality.
3. Elimination of Uncertainty: There must be a technological uncertainty at the outset regarding the capability, method, or design of the business component.
4. Process of Experimentation: The taxpayer must engage in a systematic process to evaluate one or more alternatives to achieve the desired result (e.g., modeling, simulation, or trial and error).

Documentation Best Practices

Taxpayers are advised to maintain contemporaneous records to support their R&D claims. According to industry guidance and state requirements, these should include:

• Payroll Records: Documentation linking specific employee time to R&D projects.
• Project Narratives: Descriptions of technical challenges and the experimentation process.
• Evidence of Nexus: Receipts, invoices, and contracts proving that research expenditures occurred specifically within New York State.
• Technical Artefacts: Lab notes, prototypes, patent applications, and testing results.

The DTF notes that failure to provide contemporaneous documentation is one of the most common reasons for credit disallowance. If a participant fails to meet its job or investment targets in any given year, it loses the credit for that year entirely, and such failure does not extend the original 10-year benefit window.

Economic Impact and Statistical Overview (2024 Data)

The scale of the Excelsior Jobs Program as an economic development tool is reflected in recent annual reports from Empire State Development.

2024 Program Performance Statistics

As of June 30, 2024, the program’s reach is extensive across the state’s various economic regions:

• Total Committed R&D Expenditures: Businesses admitted to the program have committed to a total of over $2.96 billion in research and development spending.
• Active Projects: 796 projects are currently admitted to the program, representing a committed capital investment of over $8.71 billion.
• Historical Payouts: Since the program’s inception, 421 projects have been issued over $418.80 million in tax credits, with an additional $190.10 million scheduled for performance reports in tax year 2024.
• Regional Distribution: The program is balanced between Upstate (413 projects) and Downstate (383 projects), indicating that the R&D credit is a vital tool for both NYC’s biotech corridor and Upstate’s manufacturing hubs.

These statistics underscore a significant insight: the Excelsior R&D credit is not a niche incentive but a primary engine for high-tech capital formation in the state. The $1.27 billion in reported R&D expenditures from just 34 completed projects demonstrates the massive scale of individual corporate research initiatives supported by the program.

Strategic Final Thoughts and Recommendations

The Excelsior Research and Development Tax Credit is a powerful, albeit complex, instrument of New York State tax policy. By anchoring the credit to federal definitions while providing for full refundability, the state has created a mechanism that significantly lowers the cost of innovation for high-growth firms. However, the discretionary nature of the program means that businesses cannot treat it as an after-the-fact tax filing. Instead, it requires a proactive, 10-year strategic partnership with the state.

For businesses looking to maximize the benefit of this credit, the following strategic considerations are paramount:

• Early Engagement: Companies should apply via the CFA process well before commencing significant new hiring or capital investment.
• Holistic Planning: Because the R&D credit is just one of five EJP components, businesses should model the interaction between the jobs credit, the investment credit, and the R&D credit to maximize their total refund.
• Technical Rigor: Success in the program requires a sophisticated understanding of both federal IRC Section 41 and New York State Tax Law Articles 9-A or 22. Engaging with professionals who can navigate the dual requirements of ESD and DTF is essential for maintaining eligibility over the decade-long benefit period.

As New York moves toward a 2039 sunset for the Excelsior Jobs Program, and as initiatives like Green CHIPS take root, the R&D tax credit will remain the state’s most potent lever for ensuring that the technologies of the future are researched, developed, and commercialized within its borders. The shift from “as-of-right” zones to “pay-for-performance” credits has fostered an environment where only the most accountable and productive firms thrive, ultimately securing a higher return on investment for the state’s economic future.